Smilow Cancer Center at Yale New Haven Hospital is a clinical research site located in New Haven, Connecticut, United States 06510.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Smilow Cancer Center at Yale New Haven Hospital has participated in 6 clinical trials with 2 currently active.
Therapeutic areas: Head and Neck Squamous Cell Carcinoma, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic.
Sponsors: Yale University, Millennium Pharmaceuticals, Inc., Pfizer.
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Smilow Cancer Center at Yale New Haven Hospital has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Smilow Cancer Center at Yale New Haven Hospital has 6 clinical trials on record, with 2 currently active. Their work covers Head and Neck Squamous Cell Carcinoma, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic.
Yes — Smilow Cancer Center at Yale New Haven Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.